The study also reported that TMEFF2 overexpression in AsPC1 and Panc1 pancreatic cancer cells (i) impairs cell proliferation both in vitro and in vivo (xenograft), (ii) decreases their invasion and migration capacities, and (iii) downregulates EMT signature proteins. Here, TMEFF2 is linked to familial pancreatic carcinoma.